Leap Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LPTX and buy or sell other stocks, ETFs, and their options commission-free!About LPTX
Cypherpunk Technologies, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer.
CEODoug E. Onsi
CEODoug E. Onsi
Employees52
Employees52
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees52
Employees52
LPTX Key Statistics
Market cap144.00M
Market cap144.00M
Price-Earnings ratio-1.06
Price-Earnings ratio-1.06
Dividend yield—
Dividend yield—
Average volume8.03M
Average volume8.03M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.70
52 Week high$3.70
52 Week low$0.2223
52 Week low$0.2223
Stock Snapshot
With a market cap of 144M, Leap Therapeutics(LPTX) trades at $3.48. The stock has a price-to-earnings ratio of -1.06.
Leap Therapeutics(LPTX) stock opened on 2025-12-21 at —. The price climbed to — and dipped to —.
Leap Therapeutics(LPTX) shares are trading with a volume of 0, against a daily average of 8.03M.
In the last year, Leap Therapeutics(LPTX) shares hit a 52-week high of $3.70 and a 52-week low of $0.22.
In the last year, Leap Therapeutics(LPTX) shares hit a 52-week high of $3.70 and a 52-week low of $0.22.
People also own
Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.